malondialdehyde has been researched along with Body Weight, Fetal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chimini, JS; da Silva, MLS; Dias-Junior, CA; Possomato-Vieira, JS | 1 |
| El-Dakdoky, MH | 1 |
| Gandley, RE; Hubel, CA; Johnston, TP; McLaughlin, MK; Novak, J; Ramirez, RJ | 1 |
3 other study(ies) available for malondialdehyde and Body Weight, Fetal
| Article | Year |
|---|---|
Increases in placental nitric oxide, but not nitric oxide-mediated relaxation, underlie the improvement in placental efficiency and antihypertensive effects of hydrogen sulphide donor in hypertensive pregnancy.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Female; Fetal Weight; Hydrogen Sulfide; Hypertension, Pregnancy-Induced; Malondialdehyde; Neovascularization, Physiologic; Nitrates; Nitric Oxide; Nitrites; Placenta; Pregnancy; Rats; Rats, Wistar; Sulfides; Vasodilation | 2018 |
Influence of mefloquine administration during early pregnancy on rat embryonic development.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Antimalarials; Female; Fetal Weight; Fetus; Gestational Age; Glutathione; Glutathione Reductase; Liver; Malondialdehyde; Maternal Exposure; Mefloquine; Placenta; Pregnancy; Rats, Wistar; Risk Assessment; Time Factors | 2015 |
Endothelial function and myogenic reactivity in small mesenteric arteries of hyperlipidemic pregnant rats.
Topics: Animals; Blood Pressure; Cholesterol; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Nonesterified; Female; Fetal Weight; Hyperlipidemias; Malondialdehyde; Mesenteric Arteries; omega-N-Methylarginine; Poloxamer; Pregnancy; Pregnancy Complications; Rats; Rats, Sprague-Dawley; Triglycerides; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System | 2001 |